【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Zenpep/ Ultresa/ Ultrase/ Ultrase MT
04.1.2 Colomycin/ Colobreathe
04.1.3 Pulmozyme
04.1.4 Cayston
04.1.5 TOBI/ TOBI Podhaler
04.1.6 Kalydeco
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Pathophysiology
07.3 Epidemiology
07.3.1 Global
07.3.2 North America
07.3.3 Europe
07.3.4 Africas
07.3.5 Latin America
07.3.6 Middle East
07.3.7 Asia and Oceania
07.4 Diagnosis
07.4.1 Newborn Screening
07.4.2 Carrier Testing
07.4.3 Antenatal Testing
07.4.4 Other Tests
07.5 Manifestations of Cystic Fibrosis
07.6 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Molecule Type
09.1 Biologics
09.1.1 Enzymes
09.2 Small Molecules
09.2.1 CFTR Modulator
09.2.2 Antibiotics
10.Market Segmentation by Route of Administration
10.1 Oral
10.2 Parenteral
10.3 Topical
11.Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid
12.Geographical Segmentation
12.1 Cystic Fibrosis Market in the Americas
12.1.1 Cystic Fibrosis Market in the US
12.1.2 Cystic Fibrosis Market in the Latin America
12.1.3 Cystic Fibrosis Market in the Canada
12.2 Cystic Fibrosis Market in the EMEA Region
12.2.1 Market Size and Forecast
12.3 Cystic Fibrosis Market in the APAC Region
12.3.1 Market Size and Forecast
13.Key Leading Countries
13.1 US
13.2 UK
13.3 France
13.4 Canada
13.5 Italy
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 F. Hoffmann-La Roche
21.2.2 Novartis
21.2.3 Vertex Pharmaceuticals
21.2.4 Actavis
21.2.5 Gilead Sciences
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
21.1.4 Revenue by Business Segmentation
22.1.5 Revenue Comparison 2013 and 2014
22.1.6 Sales by Geography
22.1.7 Business Strategy
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Revenue by Business Segmentation
22.2.5 Revenue Comparison 2013 and 2014
22.2.6 Sales by Geography
22.2.7 Business Strategy
22.2.8 Key Developments
22.1.9 SWOT Analysis
22.3 Gilead Sciences
22.3.1 Key Facts
22.3.2 Business Description
22.3.3 Business Segmentation
22.3.4 Revenue by Business Segmentation
22.3.5 Revenue Comparison 2013 and 2014
22.3.6 Sales by Geography
22.3.7 Business Strategy
22.3.8 Key Developments
22.3.9 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Description
21.4.3 Business Segmentation
22.4.4 Revenue by Business Segmentation
22.4.5 Revenue Comparison 2013 and 2014
22.4.6 Sales by Geography
22.4.7 Business Strategy
22.4.8 Key Developments
22.4.9 SWOT Analysis
22.5 Vertex Pharmaceuticals
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2013 and 2014
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot Of Cystic Fibrosis Disease
Exhibit 3: Defects Caused by CFTR Mutation
Exhibit 4: Epidemiology of Cystic Fibrosis in the World 2012
Exhibit 5: Prevalence of Cystic Fibrosis by Country 2014
Exhibit 6: Prevalence Number of Cystic Fibrosis by Country 2014
Exhibit 7: Snapshot of US Prevalence of Cystic Fibrosis 2014
Exhibit 8: Forecast of Cystic Fibrosis Prevalence in US 2014-2019
Exhibit 9: Epidemiology Based on the Education Level in US, 2011
Exhibit 10: Epidemiology based on the Marital Status in US, 2011
Exhibit 11: Epidemiology based on the Employment Status in US, 2011
Exhibit 12: Forecast of Cystic Fibrosis Prevalence in Canada 2014-2019
Exhibit 13: Forecast of Cystic Fibrosis Prevalence in the UK 2014-2019
Exhibit 14: Age Distribution at Death for Cystic Fibrosis Patients in UK, 2013
Exhibit 15: Age Distribution by Gender for Cystic Fibrosis Patients in the UK, 2013
Exhibit 16: Age Distribution by Sex for Cystic Fibrosis Patients in the UK, 2013
Exhibit 17: Diagnosis of Cystic Fibrosis
Exhibit 18: The Manifestations of Cystic Fibrosis
Exhibit 19: Snapshot of the Economic Burden of Cystic Fibrosis
Exhibit 20: Snapshot of Global Cystic Fibrosis Market 2014
Exhibit 21: Global Cystic Fibrosis Market 2014-2019 (US$ million)
Exhibit 22: Global Cystic Fibrosis Market Segmentation By Class of Drugs
Exhibit 23: Global Cystic Fibrosis Drugs Market Segmentation by Molecule Type 2014
Exhibit 24: Global Cystic Fibrosis Market Segmentation By Route Of Administration
Exhibit 25: Global Cystic Fibrosis Drugs Market Segmentation by Route of Administration 2014
Exhibit 26: Global Cystic Fibrosis Market Segmentation by Dosage Form
Exhibit 27: Global Cystic Fibrosis Drugs Market Segmentation by Dosage Form 2014
Exhibit 28: Global Cystic Fibrosis Market by Geographical Segmentation 2014 and 2019
Exhibit 29: Global Cystic Fibrosis Market Revenue by Geographical Segmentation 2014-2019 (US$ million)
Exhibit 30: Global Cystic Fibrosis Market Growth Rate by Region 2014-2019
Exhibit 31: Revenue (US$ million) and CAGR of Global Cystic Fibrosis Market by Geographical Segments 2014 and 2019
Exhibit 32: Global Cystic Fibrosis Market by Country/Region 2014
Exhibit 33: Global Cystic Fibrosis Market by Country/Region 2014 (US$ million)
Exhibit 34: Cystic Fibrosis Market in the Americas 2014-2019 (US$ million)
Exhibit 35: Cystic Fibrosis Market Revenue in the Americas 2014-2019
Exhibit 36: Cystic Fibrosis Market Growth Rate in the Americas 2014-2019
Exhibit 37: Cystic Fibrosis Market in the Americas by Region 2014 and 2019
Exhibit 38: Revenue (US$ million) and CAGR of Cystic Fibrosis Market in the Americas by Regions 2014 and 2019
Exhibit 39: Cystic Fibrosis Market in the US 2014-2019 (US$ million)
Exhibit 40: Cystic Fibrosis Market in the Latin America 2014-2019 (US$ million)
Exhibit 41: Cystic Fibrosis Market in Canada 2014-2019 (US$ million)
Exhibit 42: Cystic Fibrosis Market in EMEA 2014-2019 (US$ million)
Exhibit 43: Cystic Fibrosis Market in EMEA by Country/Region 2014
Exhibit 44: Cystic Fibrosis Market in APAC 2014-2019 (US$ million)
Exhibit 45: Buying Criteria of Global Cystic Fibrosis Market
Exhibit 46: Global Cystic Fibrosis Market Share Analysis 2014
Exhibit 47: Global Sales Comparison of Pulmozyme 2013 vs 2012 (US$ Million)
Exhibit 48: Quarterly Sales Comparison of Pulmozyme in the US 1994-2008 (US$ Million)
Exhibit 49: Quarterly Sales Comparison of Pulmozyme Sales to Collaborators 1997-2008 (US$ Million)
Exhibit 50: Quarterly Sales Comparison of Pulmozyme Total Sales 1994-2008 (US$ Million)
Exhibit 51: Total Global Sales Comparison of Pulmozyme 1994-2008 (US$ Million)
Exhibit 52: TOBI Podhaler
Exhibit 53: YoY Sales Comparison of TOBI and TOBI Podhaler 2006-2013 (US$ Million)
Exhibit 54: YoY Sales Comparison of Kalydeco 2012-2013 (US$ Million)
Exhibit 55: Actavis: Business Segmentation 2014
Exhibit 56: Actavis: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 57: Actavis : Sales by Geography (in US$ million)
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2013 and 2014
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Diagnostics Division)
Exhibit 63: Gilead Sciences: Business Segmentation by Revenue 2014
Exhibit 64: Gilead Sciences: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Gilead Sciences: Sales by Geography 2014
Exhibit 18: Novartis AG: Business Segmentation
Exhibit 19: Novartis AG: Revenue by Business Segmentation 2014
Exhibit 20: Novartis AG: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Novartis AG: Revenue by Geographical Segmentation 2014
Exhibit 63: Vertex Pharmaceuticals: Business Segmentation by Revenue 2014
Exhibit 64: Vertex Pharmaceuticals: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Vertex Pharmaceuticals: Sales by Geography 2014
【レポート販売概要】
■ タイトル：嚢胞性線維症（CF症）治療薬の世界市場■ 英文：Global Cystic Fibrosis Market 2015-2019
■ 発行日：2014年12月17日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4842
■ 調査対象地域：グローバル
- グローバルM2Mセキュリティー及びプライバシー市場：課題と機会Machine-to-Machine (M2M) applications will be developed in various sectors of the industry at a rapid pace over the next five years, reaching an inflexion point by 2020 as the Internet of Things (IoT) begins a high growth phase. With increasingly more devices connected to the Internet in which critical business processes depend, the threats to applications increase in terms of incidence, severity, …
- ロシアの心臓律動管理（CRM）装置市場見通しRussia Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "Russia Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the Russia Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT …
- 小型原子力発電炉の分析：Analyzing Small Nuclear Power ReactorsThe global energy jigsaw is constantly and increasingly being rearranged with the nuclear power supply. Nuclear power is increasingly presenting an alternative to become the mainstay of energy needs for the new society till the time developments are further underway for cleaner energy sources. The harnessing of this energy would not have been possible without the inventing effort of Le? Szil?rd in …
- メキシコの使い捨て病院用品市場見通し（～2021）Mexico Disposable Hospital Supplies Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Disposable Hospital Supplies Market Outlook to 2021", provides key market data on the Mexico Disposable Hospital Supplies market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Procedure Kits and Trays, Gloves, …
- アメリカの気道装置・麻酔装置市場United States Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "United States Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the United States Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circui …
- データセンターセキュリティソリューションの世界市場：論理セキュリティ、物理セキュリティThe data center security market is estimated to grow from USD 5.61 Billion in 2016 to USD 12.91 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 15.36% during the forecast period. Network security is gaining a significant importance among the corporates due to the increasing number of untrusted devices accessing their networks. Hence, the adoption of NAC in various industries is in …
- 世界のマスターバッチ（樹脂用着色剤）市場：ブラック/ホワイト/カラー/添加剤マスターバッチAbout Masterbatch Masterbatches are additives or pigments, which are in concentrated form, used for coloring or imparting desired properties to polymers. Masterbatch allows the molder to improve the appearance and performance of the raw polymer or resin in a cost-effective manner during the plastics manufacturing process. They are broadly classified into four types: black, white, color, and additi …
- Italian HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Commercial Labs–Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT ProceduresComplete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in Italy. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals …
- バイオ農薬の世界市場：バイオ除草剤、バイオ殺虫剤、バイオ殺菌剤、バイオ殺線虫剤About Bio-pesticides Bio-pesticides are developed using pathogenic microorganisms, and are used to target a specific pest, which offers an eco-friendly and effective pest control solution. The mostly utilized biopesticides are living organisms that are pathogenic in nature and can destroy the target pest. The following benefits offered by bio-pesticides make them preferable than conventional synth …
- 胃酸過多/胸やけ/呑酸(Acid Indigestion / Heartburn/ Pyrosis)：世界の治験レビュー（2015年上半期版）Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2015" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartbur …
- 静止画像の世界市場2017-2021：写真、その他About Still ImagesStill images comprise photographs, presentations, posters, vectors, graphic images, and infographics. Technavio’s analysts forecast the global still images market to grow at a CAGR of 7.76% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global still images market for 2017-2021. To calculate the market s …
- 世界のトンネル及び掘削機械市場：主要動向及び市場機会This report provides detailed market analysis, information, trends, issues and insights into the global tunneling and drilling equipment market, including: • The regional and global tunneling and drilling equipment market’s growth prospects by category • Separate analysis of the Asia-Pacific, Middle East, North America, Latin America and Europe markets with country-level data • Critical insight in …
- 睡眠ポリグラフ装置の世界市場2019-2023Global Polysomnography Devices Market: About this market Technavio’s polysomnography devices market analysis considers sales from hospitals, sleep clinics and diagnostic laboratories, ASCs, and homecare. Our analysis also considers the sales of polysomnography devices in Asia, Europe, North America, and ROW. In 2018, the hospitals' segment had a significant market share, and this trend is expected …
- 頸椎前方固定術デバイスの世界市場2016-2020About Anterior Cervical Fixation Anterior cervical fixation is performed surgically to treat damaged/herniated discs that cause compression of spinal cord or nerve root. The surgery stabilizes the corresponding vertebrae, and the pain is decompressed by fixing the anterior fixation system with essential anterior plating, screws, and implants. Technavio’s analysts forecast the global anterior cervi …
- TVコンテンツホルダーのOTT戦略This report spotlights premium content right holders' strategies to tap the new internet territories. It provides a benchmark of OTT services launched by major rightholders. The study also provides the analyses and conclusions on these OTT strategies in highlighting their drivers and hurdles: technology, regulation, consumption patterns. Finally, it addresses the question of viability of an exclus …
